Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic receives FDA nod for treating chronic kidney disease
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
F.D.A. Approves Ozempic to Treat Kidney Disease
The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.
FDA approves Ozempic to help reduce risk of worsening chronic kidney disease
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of
1d
US FDA clears Ozempic for use in diabetics with chronic kidney disease: What does it mean for you?
It showed that 1 mg Ozempic led to a 24 per cent reduced risk of worsening kidney disease and kidney failure (end-stage ...
News Nation on MSN
4d
Ozempic can help other chronic health conditions: Study
GLP-1 weight loss drugs such as Ozempic are known to promote weight loss, but they have other benefits according to a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
All aboard feared dead
Los Angeles wildfire updates
Cause of death revealed
Asteroid may hit Earth
Michigan priest loses license
Agency halts events
Signs education orders
Ex-worker admits to theft
Victims of DC plane crash
Blames DEI for crash
'As Tears Go By' singer dies
Hamas confirms death
Searching for joyriders
S3 release date revealed
Deputy shooting sentence
DOJ weighs dropping case?
Presidential historian dies
Wildfire erupts in NC
Shiffrin finishes 10th
Weekly jobless claims fall
Nashville bids for franchise
Day 2 of Senate hearing
Ebola outbreak in Uganda
Gun trafficking indictments
First spacewalk together
Jury weighs charges
US economy grew 2.3%
Hamas frees more hostages
Syria’s transitional pres
Senate confirmation hearing
Zeldin confirmed by Senate
Plans job, output cuts in US
In talks to invest in OpenAI
Related topics
Novo Nordisk
Food and Drug Administration
Diabetes mellitus type 2
Feedback